Fluoroquinolones are broad-spectrum and highly bactericidal antimicrobials agents that are used to treat various bacterial infections. Escherichia coli infections, especially in the urinary tract, are frequently treated with fluoroquinolones, and fluoroquinolone resistance has increased in the clinical field. Fluoroquinolone resistance is caused mainly by chromosomal mutations in the quinolone resistance-determining region (QRDR) of gyrA and gyrB, which encode DNA gyrase subunits, and parC and parE, which encode topoisomerase IV subunits. Moreover, plasmid-mediated quinolone resistance (PMQR) genes have been reported in Gram-negative bacteria, including E. coli. The acquisition of PMQR genes alone results in a low level of fluoroquinolone resistance and does not lead to MICs exceeding the breakpoints of these agents.
in 2003 (6) . It confers resistance to several antimicrobial agents, such as olaquindox, trimethoprim, and chloramphenicol, and a slight decrease in susceptibility to fluoroquinolones (3) . Isolation of oqxAB-harboring Enterobacteriaceae has been reported only in Sweden and Denmark, South Korea, and China (3, 5, 7) , and isolates derived from human patients have been reported only in South Korea. This letter provides the first report of oqxAB-harboring E. coli in Japan. Zhao et al. reported the isolation of E. coli harboring both qnrS and oqxAB from pigs in China (7) . These isolates showed no mutations in the QRDR of gyrA and parC, however, mutations in that of parE and gyrB have not been determined. These isolates showed CIP MICs of 1 to 2 g/ml, and they are therefore susceptible or intermediate according to the CLSI breakpoints.
OqxAB and QnrS increase the MIC of CIP approximately 32-fold and 64-fold, respectively (1, 5) . These reports suggest that fluoroquinolone resistance in HUE1 without mutations in QRDR is caused by the concomitant presence of oqxAB and qnrS. However, other mechanisms may be associated with fluoroquinolone resistance in HUE1; therefore, further investigations are needed.
In conclusion, we present the first report of fluoroquinolone resistance in an E. coli isolate that is independent of mutations in the QRDR. The isolate harbored two PMQR genes, qnrS and oqxAB.
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